RxDoctor Payments Data

Regina Henry, MD

Infectious Disease · Kansas City, MONPI 1134182967

Payments from drug & device makers

No general payments reported

No drug or device maker reported general payments to this provider for 2019–2025. That is a common and unremarkable result.

How this compares

$0 in reported general payments places this provider in the 5th percentile of 177 infectious disease providers in Missouri.

See all infectious disease providers in Missouri

Medicare billing

Part B allowed, 2024
$686,239
Medicare patients
380
Services billed
80,710

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
GenvoyaElviteg/Cob/Emtri/Tenof Alafen24$97,431
BiktarvyBictegrav/Emtricit/Tenofov Ala17$91,390
DovatoDolutegravir Sodium/Lamivudine14$41,673
JulucaDolutegravir/Rilpivirine12$41,469
Doxycycline Hyclate44$902
Cephalexin29$500
CefuroximeCefuroxime Axetil17$339
Amoxicillin13$161
Azithromycin11$99

Paid to pharmacies, not to this prescriber.

Other infectious disease in Kansas City

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →